GH NASDAQ
Guardant Health, Inc.
1W: +19.6%
1M: +31.8%
3M: +14.5%
YTD: +16.0%
1Y: +195.2%
3Y: +323.1%
5Y: +7.5%
$118.95
+0.94 (+0.80%)
Weekly Expected Move ±6.0%
$84
$89
$95
$101
$106
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (79)
Guardant Health Secures FDA Approval For Expanded Liquid Biopsy Test
Guardant Health (GH) Q1 2026 Earnings Transcript
Guardant Health CMO resigns
Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates
Guardant Health Non-GAAP EPS of -$0.45 beats by $0.02, revenue of $301.7M beats by $22.64M
Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy
William Blair updates conviction stock list
Pfizer, Arvinas breast cancer therapy approved by the FDA
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Why Is Guardant Health Stock Falling On Tuesday?
B. Metzler seel. Sohn & Co. AG Takes Position in Guardant Health, Inc. $GH
Guardant Health, Inc. $GH Shares Acquired by Assetmark Inc.
Guardant Health, Inc. $GH Holdings Lowered by Baillie Gifford & Co.
Cloudflare, ServiceNow, And Guardant Health Are Among Top 10 Large-Cap Losers Last Week (April 6-April 10): Are the Others in Your Portfolio?
Guardant Health (NASDAQ:GH) Trading Down 7% – Here’s What Happened
Terilyn Monroe Sells 3,832 Shares of Guardant Health (NASDAQ:GH) Stock
Aberdeen Group plc Sells 40,577 Shares of Guardant Health, Inc. $GH
SG Americas Securities LLC Invests $1.74 Million in Guardant Health, Inc. $GH
Guardant Health, Inc. $GH is Capricorn Fund Managers Ltd’s 6th Largest Position
Harbor Capital Advisors Inc. Purchases Shares of 9,936 Guardant Health, Inc. $GH
Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Rating of “Moderate Buy” from Analysts
Allspring Global Investments Holdings LLC Reduces Stock Holdings in Guardant Health, Inc. $GH
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook?
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook?
Tempus AI Reinforces Market Position With Collaborations in 2026
Connective Portfolio Management LLC Acquires Shares of 7,000 Guardant Health, Inc. $GH
Algert Global LLC Raises Stock Holdings in Guardant Health, Inc. $GH
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions
Guardant Health, Inc. $GH Shares Bought by Aquatic Capital Management LLC
Atika Capital Management LLC Has $8.31 Million Position in Guardant Health, Inc. $GH
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth?
ARK Investment Management LLC Sells 2,028,263 Shares of Guardant Health, Inc. $GH
Amova Asset Management Americas Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH
Guardant Health acquires Israeli healthtech MetaSight for up to $150M
Guardant Health outlines 27%–30% revenue growth for 2026 while expanding Shield and oncology portfolio
Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Rating of “Moderate Buy” from Analysts
Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know
Guardant Health to Participate in Upcoming Investor Conferences
Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions
Should You Buy Guardant Health Before Feb. 19?
Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Guardant Health, Inc. $GH Shares Bought by Federated Hermes Inc.
Alta Wealth Advisors LLC Purchases Shares of 6,496 Guardant Health, Inc. $GH
Guardant Health: Look For Explosive Revenue Growth Ahead
Gamehost (TSE:GH) Share Price Passes Below 200 Day Moving Average – Here’s Why
FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Guardant Health, Inc. $GH Shares Bought by Emerald Advisers LLC
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth
Guardant Health, Inc. (GH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Guardant Health, Inc. $GH Shares Sold by D.A. Davidson & CO.
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
Terilyn Monroe Sells 10,031 Shares of Guardant Health (NASDAQ:GH) Stock
Guardant Health (NASDAQ:GH) Reaches New 1-Year High – Here’s Why
Guardant Health Catapults 234%; Sets Up With Strong Sales Outlook
Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families
Gamehost (TSE:GH) Share Price Passes Above 50-Day Moving Average – Here’s What Happened
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Guardant Health, Inc. $GH
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of “Moderate Buy” by Analysts
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of “Moderate Buy” by Brokerages
Where To Invest In 2026: Top 5 Secular Growth Trends
Darya Chudova Sells 5,451 Shares of Guardant Health (NASDAQ:GH) Stock
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy
Federated Hermes Inc. Has $76.26 Million Position in Guardant Health, Inc. $GH
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium
Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year?
Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of “Moderate Buy” by Brokerages
Creative Planning Purchases 11,449 Shares of Guardant Health, Inc. $GH
Gamehost (TSE:GH) Stock Passes Below 200 Day Moving Average – Here’s Why